Login / Signup

Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.

Óskar Ö HálfdánarsonKatja FallMargret H OgmundsdottirSigrún H LundEiríkur SteingrímssonHelga M OgmundsdottirHelga Zoega
Published in: Pharmacoepidemiology and drug safety (2018)
Our findings do not support a chemopreventive effect of PPI use on breast cancer, prostate cancer, or malignant melanoma.
Keyphrases
  • prostate cancer
  • radical prostatectomy